The mushroom extract schizophyllan reduces cellular proliferation and induces G2/M arrest in MCF-7 human breast cancer cells

Life Science Journal

Volumn 8, Issue 4, 2011, Pages 777-784

  Aleem, Eiman ^a  

^a Alexandria University Faculty Of Science   (Egypt)

Author keywords

Apoptosis; CDK1; Cell cycle; MCF 7 cells; Mushroom; P53; Schizophyllan; Schizophylum commune

Indexed keywords

BASIDIOMYCOTA; MUS;

EID: 84860514998     PISSN: 10978135     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Aleem A, Daba A, Baddour N, El-Saadani M and Mansour A. (2011). Schizophyllan decreases the incidence of DMBA-induced mammary tumors in mice through reduction in cell proliferation without inducing apoptosis. Proceedings of the American Association for Cancer Researcher's special conference on Advances in Breast Cancer Research: Genetics, Biology and Clinical Applications p.138.
2. Ahmed, S. A., Gogal, R. M., Jr., and Walsh, J. E. (1994). A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay. Journal of immunological methods 170, 211-224.
3. Bernstein, L., Deapen, D., Cerhan, J. R., Schwartz, S. M., Liff, J., McGann-Maloney, E., Perlman, J. A., and Ford, L. (1999). Tamoxifen therapy for breast cancer and endometrial cancer risk. J Natl Cancer Inst 91, 1654-1662.
4. Desai, D., Gu, Y., and Morgan, D. O. (1992). Activation of human cyclin-dependent kinases in vitro. Molecular biology of the cell 3, 571-582.
5. Inoue, M., Tanaka, Y., Sugita, N., Yamasaki, M., Yamanaka, T., Minagawa, J., Nakamuro, K., Tani, T., Okudaira, Y., Karita, T., and et al. (1993). Improvement of long-term prognosis in patients with ovarian cancers by adjuvant sizofiran immunotherapy: a prospective randomized controlled study. Biotherapy 6, 13-18.
6. Jedinak, A., and Sliva, D. (2008). Pleurotus ostreatus inhibits proliferation of human breast and colon cancer cells through p53-dependent as well as p53-independent pathway. International journal of oncology 33, 1307-1313.
7. Jin, C. Y., Choi, Y. H., Moon, D. O., Park, C., Park, Y. M., Jeong, S. C., Heo, M. S., Lee, T. H., Lee, J. D., and Kim, G. Y. (2006). Induction of G2/M arrest and apoptosis in human gastric epithelial AGS cells by aqueous extract of Agaricus blazei. Oncology reports 16, 1349-1355.
8. Jordan, V. C. (2003). Tamoxifen: a most unlikely pioneering medicine. Nature reviews. Drug discovery 2, 205-213.
9. Kidd, P. M. (2000). The use of mushroom glucans and proteoglycans in cancer treatment. Alternative medicine review 5, 4-27.
10. Killackey, M. A., Hakes, T. B., and Pierce, V. K. (1985). Endometrial adenocarcinoma in breast cancer patients receiving antiestrogens. Cancer Treat Rep 69, 237-238.
11. Kim, Y. O., Park, H. W., Kim, J. H., Lee, J. Y., Moon, S. H., and Shin, C. S. (2006). Anti-cancer effect and structural characterization of endo-polysaccharide from cultivated mycelia of Inonotus obliquus. Life sciences 79, 72-80.
12. Kodama, N., Komuta, K., and Nanba, H. (2002). Can maitake MD-fraction aid cancer patients? Alternative medicine review 7, 236-239.
13. Kodama, N., Komuta, K., and Nanba, H. (2003). Effect of Maitake (Grifola frondosa) D-Fraction on the activation of NK cells in cancer patients. Journal of medicinal food 6, 371-377.
14. Komatsu, N., Okubo, S., Kikumoto, S., Kimura, K., and Saito, G. (1969). Host-mediated antitumor action of schizophyllan, a glucan produced by Schizophyllum commune. Gann 60, 137-144.
15. Larochelle, S., Merrick, K. A., Terret, M. E., Wohlbold, L., Barboza, N. M., Zhang, C., Shokat, K. M., Jallepalli, P. V., and Fisher, R. P. (2007). Requirements for Cdk7 in the assembly of Cdk1/cyclin B and activation of Cdk2 revealed by chemical genetics in human cells. Molecular cell 25, 839-850.
16. Lee, S. H., Hwang, H. S., and Yun, J. W. (2009). Antitumor activity of water extract of a mushroom, Inonotus obliquus, against HT-29 human colon cancer cells. Phytotherapy research: PTR 23, 1784-1789.
17. Martin, K. R., and Brophy, S. K. (2010). Commonly consumed and specialty dietary mushrooms reduce cellular proliferation in MCF-7 human breast cancer cells. Exp Biol Med (Maywood) 235, 1306-1314.
18. Miyazaki, K., Mizutani, H., Katabuchi, H., Fukuma, K., Fujisaki, S., and Okamura, H. (1995). Activated (HLA-DR+) T-lymphocyte subsets in cervical carcinoma and effects of radiotherapy and immunotherapy with sizofiran on cell-mediated immunity and survival. Gynecologic oncology 56, 412-420.
19. Nakano, T., Oka, K., Hanba, K., and Morita, S. (1996). Intratumoral administration of sizofiran activates Langerhans cell and T-cell infiltration in cervical cancer. Clinical immunology and immunopathology 79, 79-86.
20. Okamoto, K., and Sagata, N. (2007). Mechanism for inactivation of the mitotic inhibitory kinase Wee1 at M phase. Proceedings of the National Academy of Sciences of the United States of America 104, 3753-3758.
21. Okamura, K., Suzuki, M., Chihara, T., Fujiwara, A., Fukuda, T., Goto, S., Ichinohe, K., Jimi, S., Kasamatsu, T., Kawai, N., and et al. (1989). Clinical evaluation of sizofiran combined with irradiation in patients with cervical cancer. A randomized controlled study; a five-year survival rate. Biotherapy 1, 103-107.
22. Parkin, D. M. (2008). The role of cancer registries in cancer control. International journal of clinical oncology 13, 102-111.
23. Russo, A. A., Jeffrey, P. D., and Pavletich, N. P. (1996). Structural basis of cyclin-dependent kinase activation by phosphorylation. Nature structural biology 3, 696-700.
24. Solomon, M. J., Glotzer, M., Lee, T. H., Philippe, M., and Kirschner, M. W. (1990). Cyclin activation of p34cdc2. Cell 63, 1013-1024.
25. Taylor, W. R., and Stark, G. R. (2001). Regulation of the G2/M transition by p53. Oncogene 20, 1803-1815.
26. Wasser, S. P., and Weis, A. L. (1999). Therapeutic effects of substances occurring in higher Basidiomycetes mushrooms: a modern perspective. Critical reviews in immunology 19, 65-96.
27. Watanabe, N., Broome, M., and Hunter, T. (1995). Regulation of the human WEE1Hu CDK tyrosine 15-kinase during the cell cycle. The EMBO journal 14, 1878-1891.
28. Youn, M. J., Kim, J. K., Park, S. Y., Kim, Y., Kim, S. J., Lee, J. S., Chai, K. Y., Kim, H. J., Cui, M. X., So, H. S., Kim, K. Y., and Park, R. (2008). Chaga mushroom (Inonotus obliquus) induces G0/G1 arrest and apoptosis in human hepatoma HepG2 cells. World journal of gastroenterology: WJG 14, 511-517.
29. Youn, M. J., Kim, J. K., Park, S. Y., Kim, Y., Park, C., Kim, E. S., Park, K. I., So, H. S., and Park, R. (2009). Potential anticancer properties of the water extract of Inonotus [corrected] obliquus by induction of apoptosis in melanoma B16-F10 cells. Journal of ethnopharmacology 121, 221-228.
30. Zhang, M., Huang, J., Xie, X., and Holman, C. D. (2009). Dietary intakes of mushrooms and green tea combine to reduce the risk of breast cancer in Chinese women. International journal of cancer 124, 1404-1408.
31. Zhou, H., Roy, S., Cochran, E., Zouaoui, R., Chu, C. L., Duffner, J., Zhao, G., Smith, S., Galcheva-Gargova, Z., Karlgren, J., Dussault, N., Kwan, R. Y., Moy, E., Barnes, M., Long, A., Honan, C., Qi, Y. W., Shriver, Z., Ganguly, T., Schultes, B., Venkataraman, G., and Kishimoto, T. K. (2011). M402, a novel heparan sulfate mimetic, targets multiple pathways implicated in tumor progression and metastasis. PloS one 6, e21106.